Most Read Articles
5 days ago
Less focus must be given on pretreatment blood pressure (BP) levels, which rarely predict future untreated BP levels or rule out capacity to benefit from BP lowering in high cardiovascular risk patients, according to recent study. Focus must be directed instead on prompt, empirical treatment to maintain lower BP for individuals with high BP or high risk.
16 Nov 2018
Atrial fibrillation appears to be the strongest determinant of stroke over 48 years of follow-up in males, a study has found.
15 Nov 2018
Psychological functioning consistently predicts symptom severity and health-related quality of life (hr-QOL) in atrial fibrillation (AF) patients with preserved left ventricular function, a recent study has found.
Audrey Abella, 16 Nov 2018
Supplementation with either omega-3 fatty acids (ie, fish oil) or vitamin D did not reduce the incidence of major cardiovascular (CV) events (ie, composite of myocardial infarction [MI], stroke, and CV death) or total invasive cancer, according to the VITAL* trial presented at AHA 2018.

Home BP variability tied to subclinical atherosclerosis in multiple vascular beds

06 Nov 2018

Greater home blood pressure (BP) variability, particularly in home systolic (S)BP, correlates with higher carotid, aortic and peripheral but not coronary atherosclerosis burdens independent of the mean home BP, suggests a recent study.

The investigators defined SBP and diastolic (D)BP variability in a cross-sectional population-based study of 1,033 Japanese (mean age 64.0 years; 88.7 percent men) without known cardiovascular disease as variability independent of the mean (VIM) across self-measured home BP values during 7 consecutive days and quantified coronary (CAC) and aortic artery calcification (AAC) by computed tomography, carotid intima–media thickness (CIMT) by ultrasonography, and ankle–brachial index (ABI).

Multivariable-adjusted models including mean SBP showed that higher VIM of SBP correlated with CIMT >1.0 mm (relative risk [RR] fourth vs first quartile, 1.71; 95 percent CI, 1.15–2.54), AAC score >0 (RR, 1.08; 1.02–1.15) and ABI <1.1 (RR, 1.49; 1.12–1.97). In addition, linear trends were statistically significant, but no significant association was seen between VIM of SBP and CAC score >0.

On the other hand, higher VIM of DBP correlated only with AAC score >0. Associations were similar when modeling subclinical atherosclerosis severity as continuous outcomes and were consistent across subgroups based on demographics, behavioural and cardiovascular risk factors, according to the investigators.

“The mechanism by which higher BP variability causes cardiovascular events remains unclear. Experimental results indicate that alterations in vessel wall tension related to BP variability may initiate atherosclerosis through oscillatory shear stress,” the investigators said.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Cardiology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
5 days ago
Less focus must be given on pretreatment blood pressure (BP) levels, which rarely predict future untreated BP levels or rule out capacity to benefit from BP lowering in high cardiovascular risk patients, according to recent study. Focus must be directed instead on prompt, empirical treatment to maintain lower BP for individuals with high BP or high risk.
16 Nov 2018
Atrial fibrillation appears to be the strongest determinant of stroke over 48 years of follow-up in males, a study has found.
15 Nov 2018
Psychological functioning consistently predicts symptom severity and health-related quality of life (hr-QOL) in atrial fibrillation (AF) patients with preserved left ventricular function, a recent study has found.
Audrey Abella, 16 Nov 2018
Supplementation with either omega-3 fatty acids (ie, fish oil) or vitamin D did not reduce the incidence of major cardiovascular (CV) events (ie, composite of myocardial infarction [MI], stroke, and CV death) or total invasive cancer, according to the VITAL* trial presented at AHA 2018.